Kintayl Capital’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.43M Buy
129,607
+29,634
+30% +$785K 1.9% 20
2025
Q1
$2.41M Buy
99,973
+48,979
+96% +$1.18M 1.71% 23
2024
Q4
$2.05M Buy
+50,994
New +$2.05M 1.89% 16